
Oncodesign Services
Dijon, France oncodesign-services.com From their website, Nov 2026
- AAALAC
Work here? Claim this listing
About
Oncodesign Services is a contract research organization focused on preclinical pharmacology and translational sciences for oncology, immuno-oncology, inflammation, and radiopharmaceutical programs. It works with biotech and pharmaceutical teams developing small molecules, biologics, cell therapies, vaccines, viral vectors, and radiopharmaceuticals from its sites in Dijon and Paris, France.
Services
In vivo pharmacology studies
Designs and runs preclinical pharmacology studies to support proof-of-concept and development decisions.
ADME, DMPK & toxicology
In vitro biology
Provides in vitro biology work to support target and drug discovery programs.
In vivo imaging
Performs in vivo imaging studies including PET, SPECT, and preclinical MRI.
Biodistribution studies
Studies how compounds distribute in vivo to support preclinical biodistribution assessment.
PK/PD analysis
Analyzes pharmacokinetic and pharmacodynamic relationships in preclinical programs.
ADME, DMPK & toxicology
Efficacy testing
Evaluates treatment efficacy in relevant preclinical models.
Bioconjugation and radiochemistry platform
Supports radiochemistry and bioconjugation work for radiopharmaceutical development.
In vivo oncology models
Uses oncology models including syngeneic, xenograft, humanized, orthotopic, and metastatic models.
4 more services
- In vivo inflammation models
- Radiopharmaceutical development
- Discovery services
- In vitro pharmacology
Capabilities
- Assays and studies
- In vivo
- Cell therapy
- Rodent models
- ADCs
- Antibodies
- Small molecules
13 more
- PK/PD
- Bispecifics
- Peptides
- In vivo pharmacology
- In vitro biology
- PET imaging
- SPECT imaging
- Preclinical MRI
- Biodistribution
- PK/PD analysis
- Efficacy testing
- Bioconjugation
- Radiochemistry
- Therapeutic areas
- Oncology
- Immuno-oncology
- Inflammation
- Immunology
- Infectious diseases
Instruments and platforms
- PET
- SPECT
- Preclinical MRI
Modalities and species
- Modalities
- Small molecule
- Antibody
- Bispecific
- ADC
- Peptide
- Oligonucleotide
3 more
- Viral vector
- Cell therapy
- Vaccine
- Species and models
- Mouse
- Humanized mouse
- PDX models
- CDX models
- Syngeneic models
- Orthotopic models
4 more
- Ectopic models
- Ex vivo models
- TAM
- CAFs
Certifications
As the company states them, with the certificate or registry record where there is one.
AAALACSelf-reported
Scope: animal care and use program at all sites
Details
- Type
- CRO
- Founded
- 1995
- Team
- 100+ employees
- Office
- covering 19 indications. These tumors have been characterized in regar
- Sites
- Paris, France